|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.23 USD | -0.40% |
|
-4.65% | -33.15% |
| Apr. 09 | Biodesix, Inc. announced that it has received $34.999422 million in funding | CI |
| Apr. 05 | Top Midday Decliners | MT |
Biodesix, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 14.67 million compared to USD 9.61 million a year ago. Net loss was USD 9.14 million compared to USD 20.34 million a year ago.
Basic loss per share from continuing operations was USD 0.1 compared to USD 0.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -33.70% | 140M | |
| -16.58% | 8.25B | |
| +41.24% | 3.58B | |
| -39.11% | 2.46B | |
| -7.36% | 2.46B | |
| -8.95% | 2.38B | |
| -5.62% | 1.81B | |
| -19.46% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
BIODESIX, INC. 
